Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Adolescent and Young Adult Oncology, Version 2.2014 JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK Coccia, P. F., Pappo, A. S., Altman, J., Bhatia, S., Borinstein, S. C., Flynn, J., Frazier, A. L., George, S., Goldsby, R., Hayashi, R., Huang, M. S., Johnson, R. H., Beaupin, L. K., Link, M. P., Oeffinger, K. C., Orr, K. M., Reed, D., Spraker, H. L., Thomas, D. A., von Mehren, M., Wechsler, D. S., Whelan, K. F., Zebrack, B., Shead, D. A., Sundar, H. 2014; 12 (1): 21-32

Abstract

The NCCN Guidelines Insights on Adolescent and Young Adult (AYA) Oncology discuss the fertility and endocrine issues that are relevant to the management of AYA patients with cancer. Fertility preservation should be an essential part in the treatment of AYA patients with cancer. The NCCN Guidelines recommend discussion of fertility preservation and contraception before the start of treatment. Oophoropexy and embryo cryopreservation are the 2 established options for fertility preservation in women. Semen cryopreservation before the start of treatment is the most reliable and well-established method of preserving fertility in men. AYA women with cancer also have unique contraception needs, depending on the type of cancer, its treatment, and treatment-related complications. Management of cancer during pregnancy poses significant diagnostic and therapeutic challenges for both the patient and the physician. AYA women diagnosed with cancer during pregnancy require individualized treatment from a multidisciplinary team involving medical, surgical, radiation, and gynecologic oncologists; obstetricians; and perinatologists.

View details for Web of Science ID 000330333200004

View details for PubMedID 24453290